An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

Study Identifier
GMA-LTS-10-001
CT.gov Identifier
NCT01623479
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Hypotrichosis
    • Study Drug
  • bimatoprost 0.03%
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Hypotrichosis of the eyelashes * Using bimatoprost ophthalmic solution 0.03% (Latisse®) for at least 12 months
    Exclusion Criteria:
    * Use of any over-the-counter medication(s) for eyelash growth

    Protocol Summary

    This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.

    Study Locations

    Location
    Status
    Location
    Santa Ana, California, United States
    Status
    Not applicable